New Database: DrugBank Online

DrugBank Online is a comprehensive database containing information on drugs and drug targets. This bioinformatics and cheminformatics database combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. 

DrugBank Online is offered to the public as a free-to-access resource. Use and re-distribution of the content of DrugBank Online or the DrugBank Data, in whole or in part, for any purpose requires a license. Academic users may apply for a free license for certain use cases and all other users require a paid license.  If you have any questions regarding this resource, don’t hesitate to ASK US!

Race and Ethnicity-related 2022 MeSH changes

Over the last year, many stakeholders involved in scholarly publishing have been revisiting the terminology used for reporting race and ethnicity in biomedical literature, for example:

Flanagin A, Frey T, Christiansen SL; AMA Manual of Style Committee. Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals. JAMA. 2021 Aug 17;326(7):621-627. 

Flanagin A, Frey T, Christiansen SL, Bauchner H. The Reporting of Race and Ethnicity in Medical and Science Journals: Comments Invited. JAMA. 2021 Mar 16;325(11):1049-1052. 

In 2022, the National Library of Medicine, producer of PubMed/MEDLINE, also made changes to the Medical Subject Headings (MeSH) related to race and ethnicity, replacing multiple headings with more up-to-date terminology that better matches with the latest United States Census terminology. Among the 24 changes to MeSH headings this year were:

African Continental Ancestry Group >>>> Blacks
American Natives  >>>>  American Indians or Alaska Natives
Asian Continental Ancestry Group  >>>>  Asians
Continental Population Groups   >>>>  Racial Groups
Ethnic Groups >>>>  Ethnicity
European Continental Ancestry Group >>>> Whites
Hispanic Americans  >>>>  Hispanic or Latino
Oceanic Ancestry Group  >>>>  Native Hawaiian or Other Pacific Islander

Below is a more detailed view of how the MeSH Tree Structures were affected by the changes. To compare, here is the Population Groups Tree from MeSH 2021:
2022 MeSH replacements:

“Ethnicity”[Mesh]

A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.

“Racial Groups”[Mesh]

Groups of individuals with similar physical appearances often reinforced by cultural, social and/or linguistic similarities.

 

 

 

 

 

 

 


2022 MeSH additions:
(to MeSH trees other than “Population Groups”)

“Health Disparity, Minority and Vulnerable Populations”[Mesh] 

Groups of persons whose special characteristics make them a minority, vulnerable, and frequently subjected to conditions with limited levels of access to health care and other opportunities. (Most of the 2021 “Ethnic Groups” MeSH tree terms were moved here.) 

“Ethnic and Racial Minorities”[Mesh]

Socially constructed groups of people who differ in race, color or national, religious, or cultural origin from the dominant group and is often the majority population of the country in which they live. Ethnic minority groups generally share a common sense of identity and common characteristics such as language, religion, tribe, nationality, race, or a combination thereof.

 

 

 


The MeSH vocabulary is reviewed annually and revised on an “as needed” basis to best represent the latest subject matter appearing in the biomedical literature. It is not perfect and always a work in progress that grows and changes organically. Everyone is welcome to write to the NLM help desk to submit a request for a change or addition to the MeSH vocabulary.

Questions? Ask Us at the MSK Library.

New eJournal: NEJM Evidence

MSK Library has subscribed to a new multidisciplinary eJournal, NEJM Evidence. The aim of this new journal is to “focus on providing more context and critical evaluation of the methods and results to support clinical decision-making and does so in a way that respects the time and commitment of the practitioner.”

NEJM Evidence‘s research include clinical trial design, epidemiology studies, first-in-human trials, and meta-analyses.